Mersana Therapeutics buy Wedbush
Start price
15.05.25
/
50%
€0.28
Target price
15.05.26
€2.68
Performance (%)
-7.18%
Price
25.07.25
€0.26
Summary
This prediction is currently active. With a performance of -7.18%, the BUY prediction for Mersana Therapeutics by Wedbush is down slightly. This prediction currently runs until 15.05.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mersana Therapeutics | - | - |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by Wedbush for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $3.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
Stopped prediction by Wedbush for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.28
06.05.25
06.05.25
€2.66
06.05.26
06.05.26
-5.30%
25.07.25
25.07.25
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.47
03.03.25
03.03.25
€3.81
03.03.26
03.03.26
-44.40%
25.07.25
25.07.25